Case Study

Allos

Allos

Pages 2 Pages

info@veevasystems.com I 925.452.6500 I veevasystems.com VEEVA SUCCESS STORY - Allos Therapeutics THE CUSTOMER Allos is a growing biopharmaceutical company committed to the development and commercialization of innovative, anti-cancer therapeutics. Its flagship product, FOLOTYN ® , is the first and only drug approved in the U.S. for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The company

Join for free to read